MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test
At DNA Labs UAE, we offer the MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test for individuals who may be affected by this rare genetic disorder. This test can help in diagnosing and confirming the presence of Cardiofaciocutaneous syndrome type 4 (CFC4) by analyzing the MAP2K2 gene.
Test Components and Price
The MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card for analysis.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes.
Test Type and Doctor
The MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. This test is recommended to be conducted by a cardiologist.
Test Department and Pre Test Information
The test is performed in our Genetics department. Before undergoing the MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the gene MAP2K2.
Test Details
The MAP2K2 gene is associated with Cardiofaciocutaneous syndrome type 4 (CFC4), a rare genetic disorder characterized by heart defects, distinctive facial features, and abnormalities in the skin, hair, and nails. The NGS Genetic Test involves sequencing the MAP2K2 gene to identify any variations or mutations that may be responsible for CFC4.
This genetic test is beneficial in confirming a diagnosis of CFC4 in individuals displaying characteristic symptoms. It can also be used for carrier testing in family members of affected individuals or for prenatal testing in couples with a family history of CFC4.
It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals specializing in genetics. They can provide appropriate counseling and guidance based on the test results.
Test Name | MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAP2K2 Gene Cardiofaciocutaneous syndrome type 4 NGS Genetic DNA Test gene MAP2K2 |
Test Details |
The MAP2K2 gene is associated with a genetic condition called Cardiofaciocutaneous syndrome type 4 (CFC4). CFC4 is a rare genetic disorder characterized by heart defects, distinctive facial features, and abnormalities in the skin, hair, and nails. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of CFC4, an NGS Genetic Test would involve sequencing the MAP2K2 gene to identify any variations or mutations that may be responsible for the condition. This genetic test can help confirm a diagnosis of CFC4 in individuals who display characteristic symptoms. It can also be used for carrier testing in family members of affected individuals or for prenatal testing in couples with a family history of CFC4. It is important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals who specialize in genetics. They can provide appropriate counseling and guidance based on the results of the test. |